Novo Nordisk's pricing techniques within the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who may have accused the company of price tag gouging, mentioning the stark distinction between U.S. prices and people in Europe and copyright.In October 2024, Novo Nordisk published a review on scientific journal Nature a couple of nov